Oxadiazole derivatives
The present invention relates to a compound of formula (1) or a pharmaceutically acceptable salt thereof, where Q1 is a halogen atom, Q2 is a hydrogen atom or the like, X, Y and Z are a nitrogen atom or an oxygen atom, and R1 has a given structure, and a drug for the treatment and/or prophylaxis of...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TANAKA TOMOYUKI MIYAJI HIROKI ISOBE YOSHIAKI |
description | The present invention relates to a compound of formula (1) or a pharmaceutically acceptable salt thereof, where Q1 is a halogen atom, Q2 is a hydrogen atom or the like, X, Y and Z are a nitrogen atom or an oxygen atom, and R1 has a given structure, and a drug for the treatment and/or prophylaxis of a disease such as epilepsy comprising the same.
本发明涉及式(1)的化合物或其药学上可接受的盐,其中Q1为卤原子,Q2为氢原子等,X、Y和Z为氮原子或氧原子,并且R1具有给定的结构,以及用于治疗和/或预防疾病如癫痫的包含该化合物的药物。 |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115515943A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115515943A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115515943A3</originalsourceid><addsrcrecordid>eNrjZBDzr0hMyUysys9JVUhJLcosSyzJLEst5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoampoamlibGjsbEqAEAvsMh1w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Oxadiazole derivatives</title><source>esp@cenet</source><creator>TANAKA TOMOYUKI ; MIYAJI HIROKI ; ISOBE YOSHIAKI</creator><creatorcontrib>TANAKA TOMOYUKI ; MIYAJI HIROKI ; ISOBE YOSHIAKI</creatorcontrib><description>The present invention relates to a compound of formula (1) or a pharmaceutically acceptable salt thereof, where Q1 is a halogen atom, Q2 is a hydrogen atom or the like, X, Y and Z are a nitrogen atom or an oxygen atom, and R1 has a given structure, and a drug for the treatment and/or prophylaxis of a disease such as epilepsy comprising the same.
本发明涉及式(1)的化合物或其药学上可接受的盐,其中Q1为卤原子,Q2为氢原子等,X、Y和Z为氮原子或氧原子,并且R1具有给定的结构,以及用于治疗和/或预防疾病如癫痫的包含该化合物的药物。</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221223&DB=EPODOC&CC=CN&NR=115515943A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221223&DB=EPODOC&CC=CN&NR=115515943A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TANAKA TOMOYUKI</creatorcontrib><creatorcontrib>MIYAJI HIROKI</creatorcontrib><creatorcontrib>ISOBE YOSHIAKI</creatorcontrib><title>Oxadiazole derivatives</title><description>The present invention relates to a compound of formula (1) or a pharmaceutically acceptable salt thereof, where Q1 is a halogen atom, Q2 is a hydrogen atom or the like, X, Y and Z are a nitrogen atom or an oxygen atom, and R1 has a given structure, and a drug for the treatment and/or prophylaxis of a disease such as epilepsy comprising the same.
本发明涉及式(1)的化合物或其药学上可接受的盐,其中Q1为卤原子,Q2为氢原子等,X、Y和Z为氮原子或氧原子,并且R1具有给定的结构,以及用于治疗和/或预防疾病如癫痫的包含该化合物的药物。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDzr0hMyUysys9JVUhJLcosSyzJLEst5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoampoamlibGjsbEqAEAvsMh1w</recordid><startdate>20221223</startdate><enddate>20221223</enddate><creator>TANAKA TOMOYUKI</creator><creator>MIYAJI HIROKI</creator><creator>ISOBE YOSHIAKI</creator><scope>EVB</scope></search><sort><creationdate>20221223</creationdate><title>Oxadiazole derivatives</title><author>TANAKA TOMOYUKI ; MIYAJI HIROKI ; ISOBE YOSHIAKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115515943A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TANAKA TOMOYUKI</creatorcontrib><creatorcontrib>MIYAJI HIROKI</creatorcontrib><creatorcontrib>ISOBE YOSHIAKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TANAKA TOMOYUKI</au><au>MIYAJI HIROKI</au><au>ISOBE YOSHIAKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Oxadiazole derivatives</title><date>2022-12-23</date><risdate>2022</risdate><abstract>The present invention relates to a compound of formula (1) or a pharmaceutically acceptable salt thereof, where Q1 is a halogen atom, Q2 is a hydrogen atom or the like, X, Y and Z are a nitrogen atom or an oxygen atom, and R1 has a given structure, and a drug for the treatment and/or prophylaxis of a disease such as epilepsy comprising the same.
本发明涉及式(1)的化合物或其药学上可接受的盐,其中Q1为卤原子,Q2为氢原子等,X、Y和Z为氮原子或氧原子,并且R1具有给定的结构,以及用于治疗和/或预防疾病如癫痫的包含该化合物的药物。</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_CN115515943A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Oxadiazole derivatives |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T11%3A57%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TANAKA%20TOMOYUKI&rft.date=2022-12-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115515943A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |